* Repligen Corp RGEN.OQ RGEN.O is expected to show a
fall in
quarterly revenue when it reports results on February 22.
* The Waltham Massachusetts-based company is expected to
report
a 1.1% decrease in revenue to $184.559 million from $186.52
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Repligen Corp is
for
earnings of 58 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Repligen
Corp is
$230, above its last closing price of $190.00.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.68 0.68 0.77 Beat 13.2
Jun. 30 2022 0.72 0.72 0.91 Beat 27
Mar. 31 2022 0.72 0.72 0.92 Beat 27.8
Dec. 31 2021 0.65 0.65 0.81 Beat 24.9
Sep. 0.64 0.64 0.78 Beat 22.6
30 2021
Jun. 30 2021 0.52 0.52 0.79 Beat 50.8
Mar. 31 2021 0.42 0.42 0.68 Beat 60.9
Dec. 31 2020 0.31 0.31 0.52 Beat 69.8
This summary was machine generated February 20 at 14:43 GMT.
All figures in US dollars unless otherwise stated